TLSI vs. TMCI, KIDS, DCTH, CLPT, SMLR, NNOX, TCMD, NPCE, ZIMV, and CVRX
Should you be buying TriSalus Life Sciences stock or one of its competitors? The main competitors of TriSalus Life Sciences include Treace Medical Concepts (TMCI), OrthoPediatrics (KIDS), Delcath Systems (DCTH), ClearPoint Neuro (CLPT), Semler Scientific (SMLR), Nano-X Imaging (NNOX), Tactile Systems Technology (TCMD), NeuroPace (NPCE), ZimVie (ZIMV), and CVRx (CVRX). These companies are all part of the "medical equipment" industry.
TriSalus Life Sciences vs.
Treace Medical Concepts (NASDAQ:TMCI) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, community ranking, institutional ownership and dividends.
Treace Medical Concepts has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500. Comparatively, TriSalus Life Sciences has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500.
Treace Medical Concepts has higher revenue and earnings than TriSalus Life Sciences. Treace Medical Concepts is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks.
In the previous week, TriSalus Life Sciences had 1 more articles in the media than Treace Medical Concepts. MarketBeat recorded 2 mentions for TriSalus Life Sciences and 1 mentions for Treace Medical Concepts. TriSalus Life Sciences' average media sentiment score of 0.84 beat Treace Medical Concepts' score of 0.00 indicating that TriSalus Life Sciences is being referred to more favorably in the news media.
84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 2.6% of TriSalus Life Sciences shares are owned by institutional investors. 24.4% of Treace Medical Concepts shares are owned by insiders. Comparatively, 32.8% of TriSalus Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Treace Medical Concepts received 13 more outperform votes than TriSalus Life Sciences when rated by MarketBeat users. However, 100.00% of users gave TriSalus Life Sciences an outperform vote while only 47.27% of users gave Treace Medical Concepts an outperform vote.
Treace Medical Concepts has a net margin of -30.33% compared to TriSalus Life Sciences' net margin of -206.24%. TriSalus Life Sciences' return on equity of 0.00% beat Treace Medical Concepts' return on equity.
Treace Medical Concepts currently has a consensus target price of $9.99, indicating a potential upside of 5.39%. TriSalus Life Sciences has a consensus target price of $11.56, indicating a potential upside of 103.03%. Given TriSalus Life Sciences' stronger consensus rating and higher possible upside, analysts clearly believe TriSalus Life Sciences is more favorable than Treace Medical Concepts.
Summary
TriSalus Life Sciences beats Treace Medical Concepts on 11 of the 19 factors compared between the two stocks.
Get TriSalus Life Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for TLSI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
TriSalus Life Sciences Competitors List
Related Companies and Tools
This page (NASDAQ:TLSI) was last updated on 2/21/2025 by MarketBeat.com Staff
